The purpose of presenting this case was to provide insights into the concurrence of PBC, SS, and AIHA, as well as to stress the importance of serologic screening of ANA profile and repeated measurements of ANA and AMA for PBC progression and its prognosis. This evidence concerns the gene BTG3 and synovial sarcoma.